The Budapest Treaty provides a streamlined solution for patent applicants by requiring only one biological deposit to meet the obligations of multiple contracting states, thus reducing costs.
For a biological invention, simply describing the material might not suffice; a deposit is often necessary to satisfy the enablement and sufficiency requirements for patentability across jurisdictions.
In the U.S. and Europe, case law supports the use of biological deposits as a way to meet patent application requirements, highlighting the importance of proper biological material acknowledgment.
The evolution of patent law recognizes that biological materials can be difficult to communicate effectively in writing, making biological deposits a critical component of patent applications.
Collection
[
|
...
]